Stéphane Bancel: “The upside was changing humanity forever.”

Stéphane Bancel: “The upside was changing hum...

Up next

Charlamagne Tha God Live at POSSIBLE:  “Influencer means impact.”

As a Radio Hall of Fame inductee, best-selling author, TV personality, and producer, Charlamagne Tha God is a singular shaper of culture. He’s the co-host of iHeartRadio's The Breakfast Club morning show, driving millions of listeners daily, and he’s expanded his collaboration wi ...  Show more

Sherrie Westin: “As long as we’re true to our purpose, the brand is authentic.”

Working across 190 countries to deliver research-driven early learning, Sesame Workshop is the non-profit behind the longest running children’s television show and so much more. SherrieWestin is at its helm as President and CEO. Sherrie sits down with Bob to talk about the power ...  Show more

Recommended Episodes

Extraordinary leaps need solid foundations, part 1, w/Moderna CEO Stéphane Bancel
Masters of Scale

If you're launching a moonshot, success depends on how you manage the trajectory of risk. When Stéphane Bancel became Moderna's first CEO, the biotech start-up was chasing a way-out idea many experts thought was impossible. Stéphane built a culture of calculated risk-taking to cr ...  Show more

Moderna and Flagship Pioneering: Noubar Afeyan
How I Built This with Guy Raz

In the field of bio-tech, it can take 10 years and millions of dollars to see if an experimental idea might turn into a life-saving treatment—if it ever does. Noubar Afeyan fully understood those risks when he co-founded Moderna in 2010. He and his colleagues were looking for a w ...  Show more

Moderna CEO Talks New Drugs
Bloomberg Talks

Moderna CEO Stephane Bancel talks about the Moderna vaccine, drug prices, and future of the company with Bloomberg's Paul Sweeny and Matt Miller. See omnystudio.com/listener for privacy information. 

The Innovation System Behind Moderna’s Covid-19 Vaccine
HBR IdeaCast

Noubar Afeyan, cofounder and chair of Moderna Therapeutics and CEO of Flagship Pioneering, says that the breakthrough innovation behind the company’s Covid-19 vaccine came not as a stroke of luck, but from a repeatable process. He outlines a system called “emergent discovery” tha ...  Show more